This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure is particularly valuable in the development of drugs targeting the central nervous system, including potential treatments for neurological disorders such as anxiety, depression, and schizophrenia. The compound's chiral nature allows for the creation of enantiomerically pure substances, which can enhance the efficacy and reduce the side effects of the resulting drugs. Additionally, it is employed in research settings to study the pharmacological properties of piperazine derivatives, aiding in the discovery of new therapeutic agents.